[LXRX] YoY Quarter Result on 30-Sep-2010 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
08-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- -9.21%
YoY- -43.73%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 238 372 355 781 2,131 7,512 10,167 -46.48%
PBT -31,658 -29,539 -26,103 -27,539 -22,770 -28,679 -14,111 14.40%
Tax 503 -576 560 -26 -102 -1,363 -5,331 -
NP -31,658 -29,539 -26,103 -27,513 -19,142 -23,459 -14,111 14.40%
Tax Rate - - - - - - - -
Total Cost 31,896 29,911 26,458 28,294 21,273 30,971 24,278 4.64%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin -13,301.68 -7,940.59 -7,352.96 -3,522.79 -898.26 -312.29 -138.79 113.77%
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
EPS -0.43 -0.42 -0.54 -0.57 -0.98 -1.20 -0.95 -12.36%
EPS Diluted -0.43 -0.42 -0.54 -0.57 -0.98 -1.20 -0.95 -12.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.